Stay updated on VVIP in Relapsed Lymphoid Malignancies Clinical Trial
Sign up to get notified when there's something new on the VVIP in Relapsed Lymphoid Malignancies Clinical Trial page.

Latest updates to the VVIP in Relapsed Lymphoid Malignancies Clinical Trial page
- CheckyesterdayChange DetectedThe page revision stamp was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedHHS Vulnerability Disclosure and Maryland Locations were removed; Maryland location details were added under Locations, and the footer revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check46 days agoChange DetectedThe changes are minor metadata updates to the study record, adding new dates (2025-11-25, 2026-01-31, 2025-11-12), Last Update Posted (Estimated), and Revision: v3.3.2, and removing older entries such as Last Update Posted and Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study, and updated the revision to v3.3.1.SummaryDifference0.1%

- Check60 days agoChange DetectedA government funding status notice was removed from the page; core study details such as eligibility criteria, design, and outcomes remain unchanged.SummaryDifference0.3%

- Check74 days agoChange DetectedThe new screenshot shows only cosmetic updates (layout adjustments and minor wording edits); core study information such as title, eligibility criteria, objectives, and primary outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to VVIP in Relapsed Lymphoid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VVIP in Relapsed Lymphoid Malignancies Clinical Trial page.